IRIS
CUCINOTTA, Domenico Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.650
NA - Nord America 12.310
AS - Asia 7.129
SA - Sud America 2.755
AF - Africa 241
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
Totale 37.109
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.078
RU - Federazione Russa 7.204
SG - Singapore 3.023
BR - Brasile 2.379
CN - Cina 2.115
IE - Irlanda 1.866
SE - Svezia 1.565
DE - Germania 962
HK - Hong Kong 727
UA - Ucraina 705
IT - Italia 589
FR - Francia 584
FI - Finlandia 446
VN - Vietnam 418
GB - Regno Unito 358
IN - India 206
AR - Argentina 125
CA - Canada 96
BD - Bangladesh 93
PL - Polonia 83
TR - Turchia 83
MX - Messico 81
IQ - Iraq 71
EC - Ecuador 65
ZA - Sudafrica 65
AT - Austria 51
BE - Belgio 50
MA - Marocco 47
VE - Venezuela 47
ID - Indonesia 44
JP - Giappone 42
NL - Olanda 41
CO - Colombia 38
UZ - Uzbekistan 36
PK - Pakistan 35
ES - Italia 32
PY - Paraguay 31
CI - Costa d'Avorio 28
KE - Kenya 28
IR - Iran 26
UY - Uruguay 26
TN - Tunisia 22
CL - Cile 20
JO - Giordania 20
AZ - Azerbaigian 19
PE - Perù 18
CZ - Repubblica Ceca 17
DZ - Algeria 16
JM - Giamaica 16
SA - Arabia Saudita 16
AE - Emirati Arabi Uniti 15
IL - Israele 15
MY - Malesia 15
CH - Svizzera 14
NP - Nepal 14
EG - Egitto 13
LB - Libano 13
GE - Georgia 10
KR - Corea 10
HN - Honduras 9
LV - Lettonia 9
AL - Albania 8
AU - Australia 8
KZ - Kazakistan 8
PH - Filippine 8
DO - Repubblica Dominicana 7
PS - Palestinian Territory 7
RO - Romania 7
SY - Repubblica araba siriana 7
LT - Lituania 6
PA - Panama 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
EE - Estonia 5
ET - Etiopia 5
EU - Europa 5
GR - Grecia 5
GT - Guatemala 5
NZ - Nuova Zelanda 5
XK - ???statistics.table.value.countryCode.XK??? 5
AO - Angola 4
BG - Bulgaria 4
BO - Bolivia 4
HU - Ungheria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
LU - Lussemburgo 4
NG - Nigeria 4
OM - Oman 4
PT - Portogallo 4
QA - Qatar 4
BY - Bielorussia 3
DK - Danimarca 3
KH - Cambogia 3
KW - Kuwait 3
MD - Moldavia 3
MK - Macedonia 3
RS - Serbia 3
SI - Slovenia 3
SN - Senegal 3
Totale 37.078
Salva come PNG Salva come JPEG
Città #
Moscow 2.180
Dublin 1.862
Singapore 1.611
Ashburn 1.561
Jacksonville 1.432
Dallas 1.293
Chandler 1.259
Nyköping 757
Hong Kong 722
Beijing 709
San Jose 503
Princeton 338
Cambridge 329
The Dalles 323
Lauterbourg 302
Dearborn 297
Los Angeles 276
Des Moines 269
Medford 255
Boardman 224
Munich 211
São Paulo 196
Ann Arbor 195
New York 173
Buffalo 156
Bremen 141
Ho Chi Minh City 133
Messina 132
Tianjin 104
Council Bluffs 103
Jinan 96
Hanoi 90
Woodbridge 89
San Mateo 86
Wilmington 85
Shenyang 84
Redondo Beach 81
Lancaster 77
Helsinki 75
Warsaw 75
Rio de Janeiro 74
Pune 63
Belo Horizonte 56
Frankfurt am Main 55
Orem 55
Curitiba 51
Nanjing 51
Brussels 49
Guangzhou 47
Turku 47
Brooklyn 42
Zhengzhou 41
Hebei 40
Houston 40
Tokyo 40
Vienna 39
Chennai 37
Chicago 37
Porto Alegre 36
Santa Clara 36
Ningbo 35
Tashkent 35
Montreal 34
Hangzhou 33
Johannesburg 33
Brasília 32
Rome 31
Atlanta 30
Boston 30
Düsseldorf 30
Norwalk 30
Haikou 29
Quito 29
San Francisco 29
Abidjan 28
Salvador 28
Nairobi 26
Seattle 25
Baghdad 24
Campinas 24
Goiânia 24
Manchester 24
Milan 24
Shanghai 24
Taizhou 24
Denver 23
Montevideo 22
Nanchang 22
Nuremberg 22
Augusta 21
Guarulhos 21
Guayaquil 21
Shenzhen 21
Ankara 20
Da Nang 20
Manaus 20
Amsterdam 19
London 19
Stockholm 19
Baku 18
Totale 20.843
Salva come PNG Salva come JPEG
Nome #
Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). 315
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 293
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 273
A DECREASED BRAIN-STEM CONTENT OF GABA MEDIATES HYPERINSULINEMIA IN OBESE ZUCKER RATS 249
1ST-PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN CYSTIC- FIBROSIS PATIENTS WITH DIFFERENT DEGREES OF GLUCOSE-TOLERANCE 231
Altered platelet magnesium and plasma and urinary soluble form of intercellular adhesion molecule I (sICAM-1) concentrations in insulin dependent diabetes mellitus (IDDM) patients with microalbuminuria. 230
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 216
Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients. 212
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 203
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 201
CORRELATION BETWEEN URINARY ACTIVITY OF N-ACETYL-B-D-GLUCOSAMINIDASE (NAG) AND ALBUMIN EXCRETION RATE IN TYPE II (NON INSULIN-DEPENDENT) DIABETICS SUBJECTS. 198
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 197
Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse 196
Livelli di TSH e parametri metabolici in soggetti eutiroidei con diabete di tipo 2 196
Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients 195
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 195
Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome 189
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 184
Secrezione insulinica e tolleranza glucidica in dislipidemici e loro modificazioni dopo trattamento ipolipemizzante. 184
Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. 184
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 183
Cardiovascular effects of raloxifene hydrochloride 182
Anticorpi anti P-53 in pazienti con diabete mellito di tipo 1 181
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 181
Altered platetel magnesium and urinary soluble form of intercellular adhesion molecule concentrations in insulin dependent diabetes mellitus patients with microalbuminuria 180
Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study cohort 178
Autoantibodies against cytokeratin 19 in patients with type 1 diabetes mellitus 174
Very High Frequency of the Polymorphism for the Insulin Receptor Substrate 1 (IRS-1) at Codon 972 (Glycine972Arginine) in Southern Italian Women with Polycystic Ovary Syndrome. 172
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock 171
APOLIPOPROTEIN A1 GENE PROMOTER POLYMORPHISM AND CORONARY HEART-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS 168
A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee. 168
Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats. 167
[Circadian variations of T3 and T4 in euthyroid subjects]. 167
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 166
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 163
[beta-Adrenergic blockade and circadian variations of IRI]. 162
Anti-p53 autoantibodies in patients with IDDM 161
SERUM ACTIVITY OF BETA- N-ACETYLGLUCOSAMINIDASE IN OBESE HYPERINSULINEMIC SUBJECTS. 161
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. 161
[Behavior of alpha 2-macroglobulin and alpha 1-antitrypsin in mature diabetics]. 161
Age and metabolic control influence lens opacity in IDDM patients 160
Calcio e secrezione endocrina pancreatica Nota III. Efffetti di una infusione di calcio sulla secrezione glucagonica da ipoglicemia insulinica. 159
[Calcium and endocrine pancreas secretion. II. Effects of an infusion of calcium on insulin and glucagon secretion induced by intravenous administration of glucose]. 158
Correlates of total homocysteine plasma concentration in type 2 diabetes 157
[Blood cortisol changes due to insulin hypoglycemia and serum renin dynamics in the cold pressor test in normal and hypertensive subjects]. 157
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 157
[Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics]. 156
SERUM URINARY ACTIVITIES OF b-N-ACETYLGLUCOSAMINIDASE AND b-GLUCURONIDASE IN DIABETIC PATIENTS. 155
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 155
[Circadian variations of immunoreactive insulin and beta-receptors blockade]. 155
Age and metabolic control influence lens opacity in IDDM patients. 154
Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients 154
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2. 153
ADULT HEIGHT EXCEEDING TARGET HEIGHT IN A PATIENT WITH CONGENITAL PANHYPOPITUITARISM DIAGNOSED AFTER THE AGE OF 25 YEARS 152
[Behavior of plasma renin activity (PRA) after administration of a calcium antagonist]. 152
Angiogenesis in patients with bisphosphonate-associated osteonecrosis of the jaw. 151
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 151
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 151
Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study 149
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 149
Valutazione delle apoproteine A e B, delle lipoproteine e dei lipidi plasmatici durante trattamento con benzafribato in varie forme di iperlipoproteinemia. 149
Differente impatto dei polimorfismi APOC3 SST1 e CETP TAQ1B sul profilo lipidico e lipoproteico nelle donne con e senza diabete di tipo 2 149
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 148
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 146
Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects. 145
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 145
Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study 144
[P.R.A. and cold pressor test following beta receptor block during arterial hypertensive syndromes]. 144
A multicenter study on the prevalence of diabetic neuropathy in Italy 143
Alterazioni della funzione urodinamica nel diabete mellito di tipo 2 143
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 143
Effetti di un anno di trattamento con liraglutide sui principali fattori di rischio cardiovascolare in pazienti con diabete mellito di tipo 2 143
[Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese patients]. 142
[Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus] 141
[Circadian variations in glycemia and IRI in normal subjects, young and adult diabetics and in obese subjects]. 141
Gender differences in diabetic kidney disease: Focus on hormonal, genetic and clinical factors 141
Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major 140
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 140
[Fibrinolysis and the cold pressor test]. 139
[Circadian variations in blood cortisol and the rapid inhibition test with dexamethasone in primary and secondary hypertension patients]. 139
[Insulin secretion and beta-adrenergic blockade in normal subjects, obese subjects and obese diabetics after carbohydrate stimulation]. 139
[Thyroid hormones and adrenergic stimulation. II. TSH and reverse T3 behavior]. 139
[Hypertriglyceridemia, IRI and platelet aggregation]. 139
HDL subclasses and the common CETP TaqIB variant predict the incidence of microangiopatic complications in type 2 diabetic women: A 9 years follow-up study 139
[Behavior of plasma renin activity (PRA) after administration of DOCA in normal subjects]. 138
beta-Adrenergic blockade and circadian variations of IRI 137
APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I/C-III GENETIC POLYMORPHISMS AND CORONARY HEART-DISEASE IN DIABETES-MELLITUS 136
Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. 136
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 136
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 136
Glucose tolerance,insulin secretion and peripheral sensitivity in thalassemia major 135
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 135
Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus 135
Livelli di TSH e parametri metabolici in soggetti diabetici di tipo 2 eutiroidei 135
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 135
Factors affecting diabetes mellitus onset in cystic fibrosis: Evidence from a 10-year follow-up study 135
[Calcium and endocrine pancreas secretion. I. Effects of an infusion of calcium on plasma levels of insulin and glucagon]. 134
Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia 131
IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappa B and reduces the inflammatory response in myocardial ischaemia-reperfusion injury 131
Plasma insulin and glucose time courses following biliary pancreatic diversion: evaluation of two different ways of glucose loading. 131
Totale 16.410
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.439
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 0 0 0 0 0 0 0 0 81
2021/20222.102 18 267 30 84 52 7 148 87 44 447 264 654
2022/20235.338 427 360 216 398 521 519 37 339 2.280 32 163 46
2023/20241.238 88 218 90 115 93 301 20 68 18 34 12 181
2024/20255.869 72 49 102 318 286 167 129 1.387 1.594 324 491 950
2025/202616.666 757 1.150 1.369 1.289 1.323 3.838 1.964 1.968 1.969 563 252 224
Totale 37.334